95 related articles for article (PubMed ID: 4300138)
1. Presence and properties of dihydrofolate reductases within the genus Trypanosoma.
Gutteridge WE; Jaffe JJ; McCormack JJ
Br J Pharmacol; 1968 Sep; 34(1):191P-192P. PubMed ID: 4300138
[No Abstract] [Full Text] [Related]
2. Dihydrofolate reductase from Trypanosoma equiperdum. I. Isolation, partial purification, and properties.
Jaffe JJ; McCormack JJ
Mol Pharmacol; 1967 Jul; 3(4):359-69. PubMed ID: 4382281
[No Abstract] [Full Text] [Related]
3. Competitive dihydrofolate reductase binding assay of triazinate (NSC-139105), methasquin (NSC-122870), and aminopterin (NSC739).
Myers CE; Eliot HM; Chabner BA
Cancer Treat Rep; 1976 May; 60(5):615-6. PubMed ID: 1033031
[No Abstract] [Full Text] [Related]
4. Dihydrofolate reductases within the genus Trypanosoma.
Jaffe JJ; McCormack JJ; Gutteridge WE
Exp Parasitol; 1969 Aug; 25(1):311-8. PubMed ID: 5362591
[No Abstract] [Full Text] [Related]
5. Presence and properties of dihydrofolate reductases in Trypanosomatid flagellate.
Gutteridge WE; Jaffe JJ; McCormack JJ
Trans R Soc Trop Med Hyg; 1969; 63(1):119. PubMed ID: 5789067
[No Abstract] [Full Text] [Related]
6. Determination of molecular weights of dihydrofolate reductases from trypanosomatid flagellates.
Gutteridge WE; Jaffe JJ; McCormack JJ
Trans R Soc Trop Med Hyg; 1970; 64(1):174-5. PubMed ID: 5442049
[No Abstract] [Full Text] [Related]
7. Presence and properties of dihydrofolate reductases within the genus Crithidia.
Gutteridge WE; McCormack JJ; Jaffe JJ
Biochim Biophys Acta; 1969 May; 178(3):453-8. PubMed ID: 4389070
[No Abstract] [Full Text] [Related]
8. A possible histochemical mechanism of dihydrofolate reductase reaction.
Onicescu D; Taşcă L
Morphol Embryol (Bucur); 1977; 23(2):103-6. PubMed ID: 16210
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate. I. Pharmacology and pharmacokinetics.
Lippens RJ
Am J Pediatr Hematol Oncol; 1984; 6(4):379-95. PubMed ID: 6398629
[TBL] [Abstract][Full Text] [Related]
10. "Induction" of dihydrofolate reductase: purification and properties of the "induced" human erythrocyte and leukocyte enzyme and normal bone marrow enzyme.
Bertino JR; Cashmore AR; Hillcoat BL
Cancer Res; 1970 Sep; 30(9):2372-8. PubMed ID: 4394460
[No Abstract] [Full Text] [Related]
11. Comparative studies on the transport of aminopterin, methotrexate, and methasquin by the L1210 leukemia cell.
Sirotnak FM; Donsbach RC
Cancer Res; 1972 Oct; 32(10):2120-6. PubMed ID: 4404161
[No Abstract] [Full Text] [Related]
12. Number of binding sites and possible mechanisms of action.
Condit PT
Ann N Y Acad Sci; 1971 Nov; 186():363-4. PubMed ID: 4943807
[No Abstract] [Full Text] [Related]
13. 131-I-3'-iodoaminopterin: a gamma-labeled active-site-directed enzyme inhibitor.
Johns DG; Spencer RP; Chang PK; Bertino JR
J Nucl Med; 1968 Oct; 9(10):530-6. PubMed ID: 5729201
[No Abstract] [Full Text] [Related]
14. Interaction of methotrexate, folates, and pyridine nucleotides with dihydrofolate reductase: calorimetric and spectroscopic binding studies.
Subramanian S; Kaufman BT
Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3201-5. PubMed ID: 28523
[TBL] [Abstract][Full Text] [Related]
15. Role of the cellular oxidation-reduction state in methotrexate binding to dihydrofolate reductase and dissociation induced by reduced folates.
Matherly LH; Anderson LA; Goldman ID
Cancer Res; 1984 Jun; 44(6):2325-30. PubMed ID: 6609765
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and pharmacologic properties of a new folate analog, 10-deaza-aminopterin, in mice.
Sirotnak FM; DeGraw JI; Chello PL; Moccio DM; Dorick DM
Cancer Treat Rep; 1982 Feb; 66(2):351-8. PubMed ID: 7055818
[No Abstract] [Full Text] [Related]
17. [Characteristics of the nature and mechanism of action of plant folate reductases].
Andreeva NA; Bukin VN; Gofshteĭn LV
Biokhimiia; 1968; 33(2):299-305. PubMed ID: 4298765
[No Abstract] [Full Text] [Related]
18. [Mathematical description and study of the folic acid cycle reactions].
Vorontsov IN; Greshilov MM; Belousova AK; Gerasimova GK
Biokhimiia; 1980 Jan; 45(1):83-97. PubMed ID: 6783126
[TBL] [Abstract][Full Text] [Related]
19. Lack of intracellular conversion of dihydrohomofolate to tetrahydrohomofolate in leukemia cells with high levels of dihydrofolate reductase.
Nahas A; Friedkin M
Mol Pharmacol; 1972 May; 8(3):353-61. PubMed ID: 5040933
[No Abstract] [Full Text] [Related]
20. Analogues of folate antagonists as affinity and fluorescent probes of dihydrofolate reductase structure and function.
Freisheim JH; Price EM; Kumar AA; Susten SS; Smith PL; Delcamp TJ
Biochem Soc Trans; 1986 Apr; 14(2):371-3. PubMed ID: 3086153
[No Abstract] [Full Text] [Related]
[Next] [New Search]
